A'/> Cytoprotective effect of the enzyme-mediated polygallic acid on fibroblast cells under exposure of UV-irradiation
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Cytoprotective effect of the enzyme-mediated polygallic acid on fibroblast cells under exposure of UV-irradiation
【24h】

Cytoprotective effect of the enzyme-mediated polygallic acid on fibroblast cells under exposure of UV-irradiation

机译:酶介导的聚纤维酸对紫外线照射下成纤维细胞的细胞保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract The poly(gallic acid), produced by laccase-mediated oxidation of gallic acid in aqueous media (pH5.5) to attain a novel material with well-defined molecular structure and high water solubility (500mg/mL at 25°C), has been investigated to understand its potential biological activities. In this regard, a biomedical approach based on cytoprotective effect on human fibroblast cells exposed to UV-irradiation in the presence of the polymer has been demonstrated. The results also shows that 200μg/mL of poly(gallic acid) inhibits the growth and migration of dermal fibroblasts and cancer cell lines without affecting cell viability. Poly(gallic acid) pretreatment with 10μg/mL protects dermal fibroblasts from UV induced cell death and additionally, the cytoprotective effect reduce ROS presence in the cells. This property can be correlated with the antioxidant power (IC50 of 23.5μg/mL) of this novel material, which was ascertained by electronic paramagnetic resonance spectroscopy and spectrophotometrically. Additionally, the antimicrobial activity of this material was corroborated with the inhibition of Staphylococcus aureus (ATCC 25923) and Enterococcus faecalis (ATCC 29212) strains (MIC=400mg/mL) common bacteria found in hospitals.
机译:<![cdata [ 抽象 通过漆酶介导在水性介质中的无碱氧化氧化(pH 5.5)以达到具有明确定义的分子结构和高水溶性的新型材料(500 Mg / ml,在25 °C)已被调查以了解其潜在的生物活动。在这方面,已经证实了基于细胞保护作用的生物医学方法,其对聚合物暴露于聚合物的紫外线照射的人成纤维细胞。结果还表明,200 μg/ ml的聚(小酸)抑制了皮肤成纤维细胞和癌细胞系的生长和迁移而不会影响细胞活力。聚(Gallic acid)预处理10 50 的23.5 μg/ mL)这种新颖的材料,由电子顺磁共振光谱和分光光度法测定。另外,用抑制金黄色葡萄球菌的抑制来证实该材料的抗微生物活性:斜体>(ATCC 25923)和肠球菌粪便(ATCC 29212)菌株(MIC = 400 mg / ml)医院中发现的常见细菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号